magnesium sulfate has been researched along with Arteriosclerosis, Coronary in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (20.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (20.00) | 29.6817 |
| 2010's | 1 (10.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abud, B; Karaarslan, K | 1 |
| Pala, AA; Urcun, YS | 1 |
| Azarkish, F; Eftekhar, E; Farshidi, H; Hassanzadeh, M; Koochakkhani, S; Mohebi, F; Ostadhadi, S; Vaziri, MS | 1 |
| Azarkish, F; Eftekhar, E; Eslami, M; Farshidi, H; Keshavarz, M; Sobhani, AR; Soltani, N | 1 |
| Babaroglu, S; Gunaydin, S; Gunertem, OE; Kunt, AT; McCusker, K; Ozisik, K | 1 |
| Jafari, N; Mohammadzadeh, A; Towfighi, F | 1 |
| McGREGOR, M; SANDLER, A | 1 |
| MALKIEL-SHAPIRO, B | 1 |
| Akbulut, B; Reşatoğlu, AG; Uymaz, OK; Yener, A | 1 |
| Falk, E; Korsholm, TL; Ravn, HB | 1 |
5 trial(s) available for magnesium sulfate and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Comparison of Microplegia Solution and Del Nido Cardioplegia Solution in Coronary Artery Bypass Grafting Surgery: Which One is More Effective?
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Bypass; Coronary Artery Disease; Electrolytes; Female; Follow-Up Studies; Heart Arrest, Induced; Humans; Lidocaine; Magnesium Sulfate; Male; Mannitol; Middle Aged; Postoperative Period; Potassium Chloride; Retrospective Studies; Sodium Bicarbonate; Solutions; Stroke Volume; Treatment Outcome; Ventricular Function, Right; Young Adult | 2021 |
The effect of magnesium sulfate on gene expression and serum level of inflammatory cytokines in coronary artery disease patients.
Topics: Coronary Artery Disease; Cytokines; Gene Expression; Humans; Interleukin-18; Interleukin-6; Magnesium Sulfate; Tumor Necrosis Factor-alpha | 2023 |
Magnesium Sulfate Administration in Moderate Coronary Artery Disease Patients Improves Atherosclerotic Risk Factors: A Double-Blind Clinical Trial Study.
Topics: Administration, Oral; Alanine Transaminase; Aspartate Aminotransferases; Biomarkers; Capsules; Cholesterol, LDL; Coronary Artery Disease; Dietary Supplements; Double-Blind Method; Female; Humans; Iran; Lipoproteins, LDL; Magnesium Sulfate; Male; Middle Aged; Plaque, Atherosclerotic; Scavenger Receptors, Class E; Time Factors; Treatment Outcome | 2020 |
Effect of magnesium on arrhythmia incidence in patients undergoing coronary artery bypass grafting.
Topics: Aged; Arrhythmias, Cardiac; Coronary Artery Bypass; Coronary Artery Disease; Follow-Up Studies; Humans; Incidence; Magnesium; Magnesium Sulfate; Male; Middle Aged; Postoperative Complications; Reference Values; Risk Assessment; Survival Rate; Treatment Outcome | 2018 |
Supplementation of magnesium to warm blood hyperkalemic cardioplegia for the prevention of atrial fibrillation after coronary artery bypass grafting.
Topics: Atrial Fibrillation; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Artery Disease; Heart Arrest, Induced; Humans; Magnesium Sulfate; Postoperative Complications; Treatment Outcome | 2007 |
5 other study(ies) available for magnesium sulfate and Arteriosclerosis, Coronary
| Article | Year |
|---|---|
Effects of Del Nido and Terminal Warm Blood Cardioplegia on Myocardial Protection and Rhythm in Isolated CABG Patients.
Topics: Adult; Aged; Aged, 80 and over; Cardioplegic Solutions; Coronary Artery Bypass; Coronary Artery Disease; Electrolytes; Female; Heart Arrest, Induced; Heart Rate; Humans; Lidocaine; Magnesium Sulfate; Male; Mannitol; Middle Aged; Postoperative Complications; Potassium Chloride; Retrospective Studies; Sodium Bicarbonate; Solutions; Time Factors; Treatment Outcome | 2021 |
Clinical outcomes of single-dose cardioplegia in high-risk coronary bypass.
Topics: Aged; Biomarkers; Cold Temperature; Coronary Artery Bypass; Coronary Artery Disease; Electrolytes; Female; Glucose; Heart Arrest, Induced; Humans; Interleukin-6; Lidocaine; Magnesium Sulfate; Male; Mannitol; Middle Aged; Patient Readmission; Postoperative Complications; Potassium Chloride; Procaine; Prospective Studies; Risk Assessment; Risk Factors; Sodium Bicarbonate; Solutions; Time Factors; Treatment Outcome; Troponin | 2021 |
Parenteral magnesium sulphate in coronary artery disease.
Topics: Cardiotonic Agents; Coronary Artery Disease; Coronary Disease; Humans; Magnesium Sulfate | 1958 |
Further observations on parenteral magnesium sulphate therapy in coronary heart disease: a clinical appraisal.
Topics: Angina Pectoris; Coronary Artery Disease; Coronary Disease; Humans; Magnesium Sulfate; Myocardial Infarction | 1958 |
Oral magnesium supplementation induces favorable antiatherogenic changes in ApoE-deficient mice.
Topics: Administration, Oral; Animals; Apolipoproteins E; Body Weight; Cholesterol; Coronary Artery Disease; Dietary Supplements; Female; Magnesium; Magnesium Sulfate; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Myocardium; Organ Size; Triglycerides | 2001 |